Abiopharma

🔍 Marshall William Spencer (Executive)

Company: Planet Labs PBC (PL)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Sold 134,641 shares of Class A Common Stock at $30.58 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: false | shares_owned_after: 2,903,115.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").
• F2: Includes 1,958.188 RSUs that remain to vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of Issuer's Class A Common Stock each and have no expiration date.